Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018)
Abeona Therapeutics' (ABEO) quarterly Construction in Progress came in at $409000.0 in Q4 2018, down 10.11% year-on-year from $455000.0 in Q4 2017, and down 10.11% quarter-over-quarter from $455000.0 in Q4 2017.
Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018) Analysis & Trends
Abeona Therapeutics' Construction in Progress history runs 2 years deep, the most recent figure standing at $409000.0 for Q4 2018.
- On a quarterly basis, Construction in Progress fell 10.11% year-over-year to $409000.0 in Q4 2018; TTM through Dec 2018 was $409000.0, a 10.11% decrease from a year earlier, with the FY2018 full-year figure at $409000.0, down 10.11% from the prior year.
- Construction in Progress retreated to $409000.0 in Q4 2018 per ABEO's latest filing, from $455000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $455000.0 in Q4 2017 and bottomed at $409000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 409,000.00 |
| Dec 31, 2017 | 455,000.00 |